OPGN has slowly crept up ever since that insider buying in June. After meandering around the 786 fib line for weeks, the stock finally headed back toward that 618 fib line and...yet again...was rejected at that level. In general, momentum has been building in the stock but now with some attention, this 618 fib level could be an important one to keep an eye on for...
6/9/2020 Alliance Global Partners Reiterated Rating to Buy and target price to $5.00
OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease.
Aug 11 Reuters:
OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for...
Welcome Hyperspace Traveler!
This is Trial X on OPGN.
Trial X is special.
Come join me...
This would be a great place to reverse. ^evil smile^.
Let's see how this goes!
Start//: Before Snapshot.
End//: After Snapshot.
45 minute TF>
Massive Harmonic Suppression..
Amplification imminent.
This model adheres to Time-Series
Failure is a necessary component...
